U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632118) titled 'Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic... Read More
U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633821) titled '3D Hand Orthosis Trial' on June 01. Brief Summary: In people with chronic hand conditions, ... Read More
U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633275) titled 'Fronto-Parietal Transcranial Alternating Current Stimulation for ADHD in Children and Adoles... Read More
U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07631377) titled 'The LalelaLung Study: Digital Stethoscope Clinical Evaluation' on June 01. Brief Summary: P... Read More
U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07631442) titled 'The OURA Ring Study - Using Digital Health Technology to Monitor Patients With Primary Bilia... Read More
U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632846) titled 'Effect of Roflumilast as Add-On Therapy in Rheumatoid Arthritis' on May 28. Brief Summary: ... Read More
U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632261) titled 'Precision HD-tACS for Enhancing Sensory Experience in Schizophrenia' on May 27. Brief Summa... Read More
Singapore, June 9 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More
Singapore, June 9 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More
Singapore, June 9 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More